Percutaneous nephrolithotomy (PCNL) has been a popular treatment option for kidney stones since its development in the 1970s. It is a minimally invasive procedure that involves making a small incision in the patient's back and inserting a tube into the kidney to remove the stone. The procedure has been successful in treating larger stones that cannot be treated with other methods, such as shockwave lithotripsy. However, PCNL has also been associated with a number of risks, including infection, bleeding, and pain. Recently, advances in technology have allowed for a new type of PCNL, known as Outpatient Ureteroscopy and Nephrolithotomy (OUSN). This procedure is less invasive than traditional PCNL and has a lower risk of complications. In this article, we will discuss the advantages of OUSN and how it is revolutionizing the treatment of kidney stones.
OUSN is a minimally invasive procedure that combines ureteroscopy and nephrolithotomy. Ureteroscopy is a procedure in which a flexible scope is inserted through the urethra and bladder into the ureter, the tube that connects the kidney to the bladder. Through this scope, the doctor can see the stone and remove it with a basket-like device. Nephrolithotomy is a procedure in which a small incision is made in the patient's back and a tube is inserted into the kidney to remove the stone. With OUSN, the ureteroscopy and nephrolithotomy are performed in one procedure, which reduces the risk of complications and allows for a shorter recovery time.
OUSN has several advantages over traditional PCNL. First, OUSN is less invasive than PCNL, which means it has a lower risk of complications. Additionally, OUSN does not require general anesthesia, which reduces the risk of anesthesia-related complications. Finally, OUSN has a shorter recovery time than PCNL, allowing patients to return to their normal activities sooner.
OUSN is becoming increasingly popular among doctors as a way to treat kidney stones. Studies have shown that OUSN is as effective as traditional PCNL in treating larger stones, but with fewer complications and a shorter recovery time. Additionally, OUSN is often less expensive than PCNL, making it a more cost-effective option.
OUSN is a revolutionary new procedure that is revolutionizing the treatment of kidney stones. It is less invasive than traditional PCNL and has a lower risk of complications and a shorter recovery time. Additionally, OUSN is often more cost-effective than PCNL. As OUSN becomes more widely available, it is likely to become the preferred method of treating kidney stones.
1.
Biomarker-Selected Treatment Shows Promise for Bladder Preservation in MIBC
2.
FDA Investigating Blood Cancer Risk With Gene Therapy Skysona
3.
Surviving cancer, still suffering: Survey reveals gaps in follow‑up care
4.
Charles III, King of Kings, is Cancerous.
5.
The Truth About Apple AirPods
1.
How Digital Innovation and AI-Powered Case Studies are Revolutionizing Oncology Education?
2.
Advancements in Survival Mechanisms and Prognostic Determinants in Acute Myeloid Leukemia
3.
Unveiling the Hidden Mechanisms of Hemolytic Reactions
4.
Blastic Plasmacytoid Dendritic Cell Neoplasm and the Dawn of AI-powered Diagnostics
5.
Understanding Epoetin and Its Role in Treating Chronic Kidney Disease
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Current Scenario of Cancer- Q&A Session to Close the Gap
2.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part V
3.
Updates on Standard V/S High Risk Myeloma Treatment- The Next Part
4.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part I
5.
Incidence of Lung Cancer- An Overview to Understand ALK Rearranged NSCLC
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation